title: Reply to D. Milne et al.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Wentlandt
authors.forename: Monika
authors.initials: M
authors.lastname: Krzyzanowska
authors.forename: Nadia
authors.initials: N
authors.lastname: Swami
authors.forename: Gary
authors.initials: G
authors.lastname: Rodin
authors.forename: Lisa W
authors.initials: LW
authors.lastname: Le
authors.forename: Camilla
authors.initials: C
authors.lastname: Zimmermann
mesh_terms: D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D010166:Palliative Care / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians'; D012017:Referral and Consultation / Q000706:statistics & numerical data*